Boehringer Ingelheim launches University of Medicine Excellence
Ingelheim: Boehringer Ingelheim has recently announced the launch of its University of Medicine Excellence (UME).
In an unequivocal demonstration of commitment to people development and investment in a continuous learning culture, the company has officially launched UME and appointed the world-renowned Harvard Medical School (HMS) to deliver its inaugural program, 'Accelerate'. Until end of next year, Boehringer Ingelheim will invest 3.4 million USD into the program.
Until end of next year, Boehringer Ingelheim will invest 3.4 million USD into the program.
UME supports the company in attracting and developing the next generation of leading experts in clinical development and medical affairs. It will be a place where learning focuses on giving people the skills to achieve Boehringer Ingelheim's transformation goals, aimed at bringing innovative treatments to patients faster than ever before.
Read also: Boehringer Ingelheim finds Country MD for India in Vani Manja
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.